2023-04-012024-03-312024-03-31false08466583DENTISTRY 19 LTD2024-12-27falseiso4217:GBPxbrli:pure084665832023-04-01084665832024-03-31084665832023-04-012024-03-31084665832022-04-01084665832023-03-31084665832022-04-012023-03-3108466583bus:SmallEntities2023-04-012024-03-3108466583bus:AuditExempt-NoAccountantsReport2023-04-012024-03-3108466583bus:FullAccounts2023-04-012024-03-3108466583bus:PrivateLimitedCompanyLtd2023-04-012024-03-3108466583core:WithinOneYear2024-03-3108466583core:AfterOneYear2024-03-3108466583core:WithinOneYear2023-03-3108466583core:AfterOneYear2023-03-3108466583core:ShareCapital2024-03-3108466583core:SharePremium2024-03-3108466583core:RevaluationReserve2024-03-3108466583core:OtherReservesSubtotal2024-03-3108466583core:RetainedEarningsAccumulatedLosses2024-03-3108466583core:ShareCapital2023-03-3108466583core:SharePremium2023-03-3108466583core:RevaluationReserve2023-03-3108466583core:OtherReservesSubtotal2023-03-3108466583core:RetainedEarningsAccumulatedLosses2023-03-3108466583core:LandBuildings2024-03-3108466583core:PlantMachinery2024-03-3108466583core:Vehicles2024-03-3108466583core:FurnitureFittings2024-03-3108466583core:OfficeEquipment2024-03-3108466583core:NetGoodwill2024-03-3108466583core:IntangibleAssetsOtherThanGoodwill2024-03-3108466583core:ListedExchangeTraded2024-03-3108466583core:UnlistedNon-exchangeTraded2024-03-3108466583core:LandBuildings2023-03-3108466583core:PlantMachinery2023-03-3108466583core:Vehicles2023-03-3108466583core:FurnitureFittings2023-03-3108466583core:OfficeEquipment2023-03-3108466583core:NetGoodwill2023-03-3108466583core:IntangibleAssetsOtherThanGoodwill2023-03-3108466583core:ListedExchangeTraded2023-03-3108466583core:UnlistedNon-exchangeTraded2023-03-3108466583core:LandBuildings2023-04-012024-03-3108466583core:PlantMachinery2023-04-012024-03-3108466583core:Vehicles2023-04-012024-03-3108466583core:FurnitureFittings2023-04-012024-03-3108466583core:OfficeEquipment2023-04-012024-03-3108466583core:NetGoodwill2023-04-012024-03-3108466583core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108466583core:ListedExchangeTraded2023-04-012024-03-3108466583core:UnlistedNon-exchangeTraded2023-04-012024-03-3108466583core:MoreThanFiveYears2023-04-012024-03-3108466583core:Non-currentFinancialInstruments2024-03-3108466583core:Non-currentFinancialInstruments2023-03-3108466583dpl:CostSales2023-04-012024-03-3108466583dpl:DistributionCosts2023-04-012024-03-3108466583core:LandBuildings2023-04-012024-03-3108466583core:PlantMachinery2023-04-012024-03-3108466583core:Vehicles2023-04-012024-03-3108466583core:FurnitureFittings2023-04-012024-03-3108466583core:OfficeEquipment2023-04-012024-03-3108466583dpl:AdministrativeExpenses2023-04-012024-03-3108466583core:NetGoodwill2023-04-012024-03-3108466583core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108466583dpl:GroupUndertakings2023-04-012024-03-3108466583dpl:ParticipatingInterests2023-04-012024-03-3108466583dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3108466583core:ListedExchangeTraded2023-04-012024-03-3108466583dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3108466583core:UnlistedNon-exchangeTraded2023-04-012024-03-3108466583dpl:CostSales2022-04-012023-03-3108466583dpl:DistributionCosts2022-04-012023-03-3108466583core:LandBuildings2022-04-012023-03-3108466583core:PlantMachinery2022-04-012023-03-3108466583core:Vehicles2022-04-012023-03-3108466583core:FurnitureFittings2022-04-012023-03-3108466583core:OfficeEquipment2022-04-012023-03-3108466583dpl:AdministrativeExpenses2022-04-012023-03-3108466583core:NetGoodwill2022-04-012023-03-3108466583core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3108466583dpl:GroupUndertakings2022-04-012023-03-3108466583dpl:ParticipatingInterests2022-04-012023-03-3108466583dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3108466583core:ListedExchangeTraded2022-04-012023-03-3108466583dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3108466583core:UnlistedNon-exchangeTraded2022-04-012023-03-3108466583core:NetGoodwill2024-03-3108466583core:IntangibleAssetsOtherThanGoodwill2024-03-3108466583core:LandBuildings2024-03-3108466583core:PlantMachinery2024-03-3108466583core:Vehicles2024-03-3108466583core:FurnitureFittings2024-03-3108466583core:OfficeEquipment2024-03-3108466583core:AfterOneYear2024-03-3108466583core:WithinOneYear2024-03-3108466583core:ListedExchangeTraded2024-03-3108466583core:UnlistedNon-exchangeTraded2024-03-3108466583core:ShareCapital2024-03-3108466583core:SharePremium2024-03-3108466583core:RevaluationReserve2024-03-3108466583core:OtherReservesSubtotal2024-03-3108466583core:RetainedEarningsAccumulatedLosses2024-03-3108466583core:NetGoodwill2023-03-3108466583core:IntangibleAssetsOtherThanGoodwill2023-03-3108466583core:LandBuildings2023-03-3108466583core:PlantMachinery2023-03-3108466583core:Vehicles2023-03-3108466583core:FurnitureFittings2023-03-3108466583core:OfficeEquipment2023-03-3108466583core:AfterOneYear2023-03-3108466583core:WithinOneYear2023-03-3108466583core:ListedExchangeTraded2023-03-3108466583core:UnlistedNon-exchangeTraded2023-03-3108466583core:ShareCapital2023-03-3108466583core:SharePremium2023-03-3108466583core:RevaluationReserve2023-03-3108466583core:OtherReservesSubtotal2023-03-3108466583core:RetainedEarningsAccumulatedLosses2023-03-3108466583core:NetGoodwill2022-04-0108466583core:IntangibleAssetsOtherThanGoodwill2022-04-0108466583core:LandBuildings2022-04-0108466583core:PlantMachinery2022-04-0108466583core:Vehicles2022-04-0108466583core:FurnitureFittings2022-04-0108466583core:OfficeEquipment2022-04-0108466583core:AfterOneYear2022-04-0108466583core:WithinOneYear2022-04-0108466583core:ListedExchangeTraded2022-04-0108466583core:UnlistedNon-exchangeTraded2022-04-0108466583core:ShareCapital2022-04-0108466583core:SharePremium2022-04-0108466583core:RevaluationReserve2022-04-0108466583core:OtherReservesSubtotal2022-04-0108466583core:RetainedEarningsAccumulatedLosses2022-04-0108466583core:AfterOneYear2023-04-012024-03-3108466583core:WithinOneYear2023-04-012024-03-3108466583core:Non-currentFinancialInstrumentscore:CostValuation2023-04-012024-03-3108466583core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-012024-03-3108466583core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-012024-03-3108466583core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-012024-03-3108466583core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-012024-03-3108466583core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-012024-03-3108466583core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108466583core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108466583core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-012024-03-3108466583core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3108466583core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3108466583core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3108466583core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3108466583core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3108466583core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3108466583core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3108466583core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3108466583core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3108466583core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3108466583core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3108466583core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3108466583core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3108466583core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3108466583core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3108466583core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3108466583core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3108466583core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3108466583bus:Director12023-04-012024-03-3108466583bus:Director22023-04-012024-03-3108466583core:FurnitureFittingsToolsEquipment2023-03-3108466583core:FurnitureFittingsToolsEquipment2023-04-012024-03-3108466583core:FurnitureFittingsToolsEquipment2024-03-31

DENTISTRY 19 LTD

Registered Number
08466583
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2024

DENTISTRY 19 LTD
Company Information
for the year from 1 April 2023 to 31 March 2024

Directors

LAZARUS, Odette Agnes
NAPIER, Bertrand Wilfrid Dominic

Company Secretary

NAPIER, Bertrand

Registered Address

19 Bell Street
Sawbridgeworth
CM21 9AR

Registered Number

08466583 (England and Wales)
DENTISTRY 19 LTD
Statement of Financial Position
31 March 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets3225,755282,194
Tangible assets456,27956,862
282,034339,056
Current assets
Stocks56,7646,924
Debtors6287,486282,656
Cash at bank and on hand111,58752,194
405,837341,774
Creditors amounts falling due within one year7(598,950)(621,821)
Net current assets (liabilities)(193,113)(280,047)
Total assets less current liabilities88,92159,009
Creditors amounts falling due after one year8(47,359)(48,943)
Provisions for liabilities9(8,416)-
Net assets33,14610,066
Capital and reserves
Called up share capital44
Profit and loss account33,14210,062
Shareholders' funds33,14610,066
The financial statements were approved and authorised for issue by the Board of Directors on 27 December 2024, and are signed on its behalf by:
LAZARUS, Odette Agnes
Director
NAPIER, Bertrand Wilfrid Dominic
Director

Registered Company No. 08466583
DENTISTRY 19 LTD
Notes to the Financial Statements
for the year ended 31 March 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account. Goodwill represents the difference between the consideration paid for the acquisition of a business and the fair value of its identifiable net assets. It is amortised in the income statement on a straight-line basis over its estimated economic life of 20 years. In the current year, the estimated useful life of goodwill was revised to 10 years to reflect updated economic circumstances.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery4
Fixtures and fittings4
Office Equipment4
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds. The company has issued 4 ordinary shares with a nominal value of £1 each, totaling £4.00. There have been no changes to the share capital during the year, and the structure remains the same as in 2023. Dr. Odette Agnes Lazarus holds 2 ordinary shares (2023: 2 shares). Mr. Bertrand Wilfrid Dominic Napier holds 2 ordinary shares (2023: 2 shares). All shares are fully paid.
Related parties
At the start of the year, Dentistry 19 Limited owed Protea Limited £320,278.94. During the year, a movement of £11,794.58 was recorded, resulting in a closing balance of £ 308,484.36.This amount is classified under other creditors. As of the start of the year, Dentistry 19 Limited owed Dental Studio Limited £217,817.56. During the year, a movement of £45,325.16 was recorded, resulting in a closing balance of £172,492.77. This amount is classified under other creditors. At the start of the year, Sterlitzia owed Dentistry 19 Limited £242,443.11, with movement during the current year is £15,761.28 resulting in a closing balance of £258,204.39 . This amount is classified under other debtors.
2.Average number of employees

20242023
Average number of employees during the year912
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 23564,386564,386
At 31 March 24564,386564,386
Amortisation and impairment
At 01 April 23282,192282,192
Charge for year56,43956,439
At 31 March 24338,631338,631
Net book value
At 31 March 24225,755225,755
At 31 March 23282,194282,194
4.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 23171,70936,61224,048232,369
Additions41,127-2,40043,527
At 31 March 24212,83636,61226,448275,896
Depreciation and impairment
At 01 April 23130,55024,30320,654175,507
Charge for year34,2576,6563,19744,110
At 31 March 24164,80730,95923,851219,617
Net book value
At 31 March 2448,0295,6532,59756,279
At 31 March 2341,15912,3093,39456,862
5.Stocks

2024

2023

££
Raw materials and consumables6,7646,924
Total6,7646,924
6.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables11,90623,746
Other debtors258,204242,443
Prepayments and accrued income17,37616,467
Total287,486282,656
7.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables54,50045,365
Bank borrowings and overdrafts33,45825,304
Taxation and social security25,0258,688
Other creditors485,967542,464
Total598,950621,821
8.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts47,35948,943
Total47,35948,943
9.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)8,416-
Total8,416-